Edwards Lifesciences Price to Book Ratio 2010-2025 | EW
Historical price to book ratio values for Edwards Lifesciences (EW) over the last 10 years. The current price to book ratio for Edwards Lifesciences as of May 08, 2025 is 4.33.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Edwards Lifesciences Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-05-08 | 74.63 | 4.29 | |
| 2025-03-31 | 72.48 | $17.39 | 4.17 |
| 2024-12-31 | 74.03 | $17.10 | 4.33 |
| 2024-09-30 | 65.99 | $16.30 | 4.05 |
| 2024-06-30 | 92.37 | $12.46 | 7.41 |
| 2024-03-31 | 95.56 | $11.93 | 8.01 |
| 2023-12-31 | 76.25 | $11.18 | 6.82 |
| 2023-09-30 | 69.28 | $11.09 | 6.25 |
| 2023-06-30 | 94.33 | $10.60 | 8.90 |
| 2023-03-31 | 82.73 | $10.00 | 8.27 |
| 2022-12-31 | 74.61 | $9.55 | 7.82 |
| 2022-09-30 | 82.63 | $10.04 | 8.23 |
| 2022-06-30 | 95.09 | $9.59 | 9.92 |
| 2022-03-31 | 117.72 | $9.41 | 12.52 |
| 2021-12-31 | 129.55 | $9.35 | 13.85 |
| 2021-09-30 | 113.21 | $8.88 | 12.75 |
| 2021-06-30 | 103.57 | $8.24 | 12.57 |
| 2021-03-31 | 83.64 | $7.49 | 11.16 |
| 2020-12-31 | 91.23 | $7.33 | 12.45 |
| 2020-09-30 | 79.82 | $6.76 | 11.81 |
| 2020-06-30 | 69.11 | $6.18 | 11.19 |
| 2020-03-31 | 62.87 | $6.30 | 9.98 |
| 2019-12-31 | 77.76 | $19.84 | 3.92 |
| 2019-09-30 | 73.30 | $6.10 | 12.02 |
| 2019-06-30 | 61.58 | $5.61 | 10.97 |
| 2019-03-31 | 63.78 | $5.51 | 11.57 |
| 2018-12-31 | 51.06 | $5.04 | 10.13 |
| 2018-09-30 | 58.03 | $5.36 | 10.83 |
| 2018-06-30 | 48.52 | $5.04 | 9.62 |
| 2018-03-31 | 46.51 | $5.13 | 9.06 |
| 2017-12-31 | 37.57 | $4.70 | 8.00 |
| 2017-09-30 | 36.44 | $4.98 | 7.31 |
| 2017-06-30 | 39.41 | $4.64 | 8.49 |
| 2017-03-31 | 31.36 | $4.35 | 7.22 |
| 2016-12-31 | 31.23 | $4.13 | 7.57 |
| 2016-09-30 | 40.19 | $4.20 | 9.57 |
| 2016-06-30 | 33.24 | $3.87 | 8.58 |
| 2016-03-31 | 29.40 | $3.62 | 8.13 |
| 2015-12-31 | 26.33 | $3.87 | 6.80 |
| 2015-09-30 | 23.70 | $3.75 | 6.32 |
| 2015-06-30 | 23.74 | $3.55 | 6.68 |
| 2015-03-31 | 23.74 | $3.43 | 6.92 |
| 2014-12-31 | 21.23 | $6.78 | 3.13 |
| 2014-09-30 | 17.03 | $3.19 | 5.34 |
| 2014-06-30 | 14.31 | $3.01 | 4.75 |
| 2014-03-31 | 12.36 | $2.12 | 5.82 |
| 2013-12-31 | 10.96 | $2.36 | 4.65 |
| 2013-09-30 | 11.61 | $2.19 | 5.30 |
| 2013-06-30 | 11.20 | $2.35 | 4.77 |
| 2013-03-31 | 13.69 | $2.34 | 5.86 |
| 2012-12-31 | 15.03 | $2.16 | 6.97 |
| 2012-09-30 | 17.90 | $2.21 | 8.11 |
| 2012-06-30 | 17.22 | $2.07 | 8.30 |
| 2012-03-31 | 12.12 | $2.03 | 5.96 |
| 2011-12-31 | 11.78 | $1.95 | 6.03 |
| 2011-09-30 | 11.88 | $1.98 | 6.01 |
| 2011-06-30 | 14.53 | $2.01 | 7.23 |
| 2011-03-31 | 14.50 | $1.97 | 7.36 |
| 2010-12-31 | 13.47 | $1.90 | 7.11 |
| 2010-09-30 | 11.18 | $1.80 | 6.20 |
| 2010-06-30 | 9.34 | $1.65 | 5.67 |
| 2010-03-31 | 8.24 | $1.69 | 4.88 |
| 2009-12-31 | 7.24 | $3.40 | 2.13 |
| 2009-09-30 | 5.83 | $1.61 | 3.62 |
| 2009-06-30 | 5.67 | $1.48 | 3.83 |
| 2009-03-31 | 5.05 | $1.40 | 3.60 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $44.018B | $5.440B |
| Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $192.166B | 84.17 |
| Thermo Fisher Scientific (TMO) | United States | $153.961B | 18.62 |
| Alcon (ALC) | Switzerland | $47.401B | 31.51 |
| IDEXX Laboratories (IDXX) | United States | $39.134B | 44.97 |
| DexCom (DXCM) | United States | $32.682B | 50.51 |
| IQVIA Holdings (IQV) | United States | $26.521B | 14.85 |
| Mettler-Toledo (MTD) | United States | $22.538B | 26.80 |
| STERIS (STE) | Ireland | $22.108B | 25.28 |
| Waters (WAT) | United States | $20.558B | 29.01 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.317B | 0.00 |
| Hologic (HOLX) | United States | $12.352B | 13.42 |
| Sysmex ADR (SSMXY) | Japan | $11.507B | 0.00 |
| Penumbra (PEN) | United States | $11.201B | 87.92 |
| Globus Medical (GMED) | United States | $9.836B | 22.77 |
| Masimo (MASI) | United States | $8.139B | 30.02 |
| Teleflex (TFX) | United States | $5.395B | 8.90 |
| Glaukos (GKOS) | United States | $5.042B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.151B | 21.75 |
| TransMedics (TMDX) | United States | $3.241B | 94.86 |
| PROCEPT BioRobotics (PRCT) | United States | $2.939B | 0.00 |
| Veracyte (VCYT) | United States | $2.415B | 33.89 |
| LivaNova (LIVN) | United Kingdom | $2.372B | 14.12 |
| Nihon Kohden (NHNKY) | Japan | $2.127B | 11.63 |
| Elekta AB (EKTAY) | Sweden | $1.860B | 16.72 |
| Alphatec Holdings (ATEC) | United States | $1.820B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.483B | 0.00 |
| Artivion (AORT) | United States | $1.212B | 113.52 |
| Pulse Biosciences (PLSE) | United States | $1.123B | 0.00 |
| OPKO Health (OPK) | United States | $0.991B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.989B | 5.26 |
| AxoGen (AXGN) | United States | $0.746B | 0.00 |
| SiBone (SIBN) | United States | $0.744B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.654B | 14.29 |
| IRadimed (IRMD) | United States | $0.649B | 32.91 |
| Beta Bionics (BBNX) | United States | $0.623B | 0.00 |
| RxSight (RXST) | United States | $0.605B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.582B | 9.05 |
| OrthoPediatrics (KIDS) | United States | $0.539B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.469B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.453B | 0.00 |
| NeuroPace (NPCE) | United States | $0.397B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.388B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.372B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.356B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.339B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.317B | 6.73 |
| Neuronetics (STIM) | United States | $0.300B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.224B | 13.58 |
| CVRx (CVRX) | United States | $0.195B | 0.00 |
| 908 Devices (MASS) | United States | $0.194B | 0.00 |
| Inogen (INGN) | United States | $0.193B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.191B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.174B | 0.00 |
| LENSAR (LNSR) | United States | $0.163B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.148B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.145B | 0.00 |
| Accuray (ARAY) | United States | $0.140B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.126B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.125B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.105B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.100B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.094B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.087B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.085B | 0.00 |
| InspireMD (NSPR) | Israel | $0.078B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.070B | 10.55 |
| EnVVeno Medical (NVNO) | United States | $0.066B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.056B | 0.00 |
| Hyperfine (HYPR) | United States | $0.055B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.050B | 15.29 |
| Vicarious Surgical (RBOT) | United States | $0.049B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.036B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.035B | 0.00 | |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Envoy Medical (COCH) | United States | $0.032B | 0.00 |
| Spectral AI (MDAI) | United States | $0.029B | 0.00 |
| DarioHealth (DRIO) | United States | $0.029B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.013B | 0.00 |
| PAVmed (PAVM) | United States | $0.013B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.012B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.006B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.14 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |